Silo Pharma Expands into AI with Qwikagents.ai Acquisition

Silo Pharma (NASDAQ: SILO) has announced a strategic expansion into artificial intelligence as a second line of business following its acquisition of assets from Qwikagents.ai, a platform designed to deploy autonomous AI agents for tasks including research, content generation, scheduling and workflow automation. This move positions the company to capitalize on a rapidly growing AI agent market projected to reach $47 billion to $53 billion by 2030. While Silo Pharma continues to advance its core biopharmaceutical pipeline, including the SPC-15 PTSD program toward an investigational new drug application submission and Phase 1 clinical trials, the AI venture represents a new revenue stream that diversifies its business model. The company’s therapeutic focus remains on underserved conditions such as stress-induced psychiatric disorders, chronic pain, and central nervous system diseases, with programs like SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Silo’s research is conducted in collaboration with leading universities and laboratories.

The AI agent market is expected to grow significantly, and by integrating Qwikagents.ai’s technology, Silo Pharma aims to leverage automation for various business processes. The acquisition underscores a dual focus on biopharmaceutical development and emerging AI-driven revenue opportunities. Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, and this expansion into AI aligns with its strategy to explore innovative technologies. The company’s newsroom at https://ibn.fm/SILO provides the latest updates on its progress. Additionally, the full press release is available at https://ibn.fm/XJG64.

AINewsWire (AINW), a specialized communications platform focusing on AI advancements, distributed this news. AINW is part of the Dynamic Brand Portfolio @ IBN, which delivers a range of services including access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release distribution, and social media distribution. AINW aims to provide breaking news, insightful content, and actionable information to investors, influencers, and the public. The company’s website at www.AINewsWire.com offers more details.